PE PREMIER CHINA CLINICAL TRIAL
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT02230254
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 101 participants
- Sponsor
- Registry
-
NCT02230254
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02230254. Allocation not applicable; no masking; primary purpose treatment. Start 2014-04-09 (actual); primary completion 2014-06-22 (actual). Results posted on 2022-05-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PE PREMIER CHINA CLINICAL TRIAL
- Condition
- Atherosclerosis
- Intervention (Device)
- Percutaneous coronary intervention PROMUS PREMIER
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct02230254- Content hash
cd98c5bfcd96e19811fe3d0be131b876f622776cedb603f13fa32457656c405e